ArticlePneumonia (Nathan Qld.)2025
Influence of area-level social vulnerability on all-cause pneumonia, all-cause acute otitis media, and invasive pneumococcal disease incidence among Medicaid-enrolled children.
Article in Pneumonia (Nathan Qld.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe incidence of pneumococcal disease differs based on demographic and clinical factors, yet the impact of area-level social determinants of health, particularly for children, remains less understood. We characterized the relationship between individual and area-level social vulnerability and incidence of all-cause pneumonia (ACP), acute otitis media (AOM), and invasive pneumococcal disease (IPD) among children across the US.
methodsUsing a retrospective observational design, we measured disease incidence among children 18 years and younger covered by Medicaid, using claims from 2017 through 2019. We measured social vulnerability using quintiles of the county-level Minority Health Social Vulnerability Index (MHSVI) and its six subthemes (Socioeconomic Status; Household Composition and Disability; Minority Status and Language; Housing Type and Transportation; Health Care Infrastructure and Access; Medical Vulnerability). After calculating county-level ACP, AOM, and IPD incidence rates overall and among counties in each MHSVI quintile, we used Poisson regression to characterize the relationship between social vulnerability and disease incidence, controlling for confounding by child demographic characteristics. We analyzed this relationship overall and within age and race/ethnicity subgroups.
resultsAcross 38.1 million children, ACP, AOM, and IPD incidence rates were 1,767, 16,486, and 3.3 per 100,000 person-years, respectively. ACP and AOM incidence rates were lower among children in the most versus least socially vulnerable counties (unadjusted incidence rate ratio = 0.89 and 0.75, respectively; both P < 0.0001); differences were attenuated but remained statistically significant after adjusting for child demographics. The direction of the relationship between ACP and AOM incidence and vulnerability varied by type of vulnerability: incidence was lower in counties that were most (versus least) vulnerable based on Minority Status and Language or Housing Type and Transportation, but higher in those most vulnerable based on Household Characteristics or Disability and Medical Vulnerability. Differences in IPD incidence between the most versus least vulnerable counties were generally non-significant, due to the low overall incidence.
conclusionsIncidence of AOM and ACP in children varies significantly by demographic characteristics and county-level medical and non-medical social determinants of health. Social vulnerability may be useful to identify factors associated with disparities in pneumococcal disease and develop targeted interventions to reduce them.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.